SUMMARY
Andrew J. Meltzer, M.D., M.B.A., is a board-certified vascular surgeon, with special expertise in minimally invasive vascular surgery. He also is an accomplished researcher. In addition to managing his clinical practice, Dr. Meltzer studies the safety and effectiveness of new technologies.
Dr. Melzer's research focuses on surgical outcomes and comparative effectiveness in vascular surgery. He is the recipient of intramural and extramural local grants and grants from the National Institutes of Health and the United States Food and Drug Administration. He has served as co-investigator and site principal investigator on numerous clinical trials.
Focus areas
- Treatment of the full spectrum of vascular diseases, from complex aortic aneurysms to venous insufficiency.
- Expertise with the most advanced minimally invasive endovascular techniques as well as traditional open vascular surgery.
- Commitment to a patient-centered approach and individualized treatment plans.
Significance to patient care
Dr. Meltzer's clinical practice covers the full range of vascular surgery, from complicated aortic surgery to the treatment of venous disease. He has a special interest in the use of new, minimally invasive solutions to treat complex arterial problems.
Professional highlights
- Member, Executive Council, Rocky Mountain Vascular Society, 2022-present.
- Society for Vascular Surgery:
- Chair, Medical Malpractice Working Group, 2020-present.
- Member, Wellness Task Force, 2019-present.
- Member, Quality and Performance Measures Committee, 2015-present.
- Vascular and Endovascular Surgery Society:
- Member, Annual Meeting Program Committee 2018-present.
- Member, Communications Committee, 2014-2015.
- Member, Clinical Event Committee, BEST-CLI Trial, 2016-present.
- Fellow, American College of Surgeons, 2014-present.
- Reviewer:
- Annals of Vascular Surgery, 2012-present.
- Journal of Vascular Surgery, 2012-present.
- Surgery, 2012-present.
- Vascular, 2012-present.
- Vascular and Endovascular Surgery, 2012-present.
- Principal investigator, Evaluation of the Gore Excluder Thoracoabdominal Branch Endoprosthesis in the Treatment of Thoracoabdominal and Pararenal Aortic Aneurysms, Mayo Clinic, 2021-2027.
- Member, Medical Device Epidemiology Network, Food and Drug Administration, 2016-2018.